The Shred Stack Explained: Why Reta + Tesa + MOTS-C Goes Together

Stacks — 2026-05-07

The Shredder Stack — Reta + Tesamorelin + MOTS-C — has become one of the most-studied recomposition protocols in our research catalog. The reason is mechanistic: each compound works on a different axis, and the combination addresses every major lever of body composition simultaneously without redundancy. This article walks through the logic of why these three peptides are paired together.

Researchers running stack protocols: code WELCOME unlocks 35% off the entire Shredder Stack (1× Reta 20mg + 1× Tesa + 1× MOTS-C) and the extended Shredder Stack Complete (1× Reta 20mg + 3× Tesa + 3× MOTS-C) at checkout. Complete is a full month of all three — the cleanest way to source matched-batch material for each month of a 12- or 26-week study.

The Three Levers of Body Recomposition

When researchers think about altering body composition, three biological levers matter:

1. Energy intake — what enters the system (appetite, satiety, food choice)
2. Energy expenditure — what leaves the system (basal metabolism, thermogenesis, activity)
3. Substrate partitioning — how the body uses what's there (fat oxidation vs. storage; lean mass preservation vs. catabolism)

Most weight-loss compounds target only one or two of these. The Shredder Stack hits all three by design.

Reta: The Energy Deficit Driver

Reta is a triple agonist (GP-1, GIP, glucagon) and does the heavy lifting on the energy deficit:

• GP-1 receptor activation suppresses appetite via central pathways and slows gastric emptying — energy intake drops
• GIP receptor activation improves insulin sensitivity and modulates adipose tissue signaling
• Glucagon receptor activation is the differentiator — it increases resting energy expenditure and promotes hepatic fat oxidation

The Phase 2 trial showed ~24% body weight reduction at 48 weeks at the 12 mg dose, the largest effect of any single peptide compound studied to date. But weight loss this large carries a known risk: disproportionate lean mass loss. That's where Tesamorelin enters.

Tesamorelin: The Lean Mass Preservation Layer

Tesamorelin is a GHRH analog. Daily 2 mg subcutaneous injection produces a pulsatile growth hormone release, which drives downstream IGF-1 elevation. The relevant research findings:

• Visceral adipose tissue (VAT) reduction — independent of caloric balance, tesamorelin shifts fat distribution away from visceral depots specifically
• Lean mass preservation — IGF-1 elevation is anabolic for skeletal muscle and works against the catabolic pressure of an aggressive energy deficit
• Modest lipid improvements — triglycerides and total cholesterol typically improve

In a recomp protocol where reta is producing a steep energy deficit, tesamorelin is the counterweight that keeps the weight loss compositionally favorable. Without it, the body composition outcome is essentially a steeper version of standard caloric-deficit weight loss — which is not what most recomp research is targeting.

MOTS-C: The Mitochondrial Layer

MOTS-C is a mitochondrial-derived peptide encoded by mitochondrial DNA. It activates AMPK — the cellular energy-sensing pathway that exercise activates. Research has shown:

• Improved fat oxidation at the mitochondrial level
• Enhanced glucose tolerance in animal models
• Exercise-mimetic metabolic effects — many of the metabolic benefits of exercise are AMPK-mediated, and MOTS-C partially recreates them
• Mitochondrial efficiency improvements that compound over weeks of administration

In the Shredder Stack, MOTS-C addresses something neither reta nor tesamorelin do: it changes how the cell handles fuel. Reta creates the deficit, tesamorelin preserves muscle, and MOTS-C improves the substrate partitioning so the deficit is filled preferentially from fat.

Why the Three Don't Overlap

A common mistake in stack design is including compounds that do the same thing. The Shredder Stack avoids this:

No two compounds share a primary mechanism. That's the design point.

The Stack in a Research Protocol

The standard monthly configuration:

• Reta: weekly subcutaneous, titrated from 2 mg toward a 4 mg target (up to 6-8 mg only if results stall).
• Tesamorelin: 1 mg nightly subcutaneous (aggressive phase 1.5-2 mg), continuous.
• MOTS-C: 8 mg per week (4 mg twice weekly).

At those doses the vials don't stretch far: one Tesa 10mg vial covers ~10 days and one MOTS-C 10mg vial ~9 days, while a Reta 20mg vial runs ~5 weeks. So the base Shredder Stack (1× of each) gives only about 10 days of the full three-compound stack. The Shredder Stack Complete adds 2 more Tesa and 2 more MOTS-C vials (3× each) — a full month of all three running together.

Common Variants and Modifications

The reduced-tesa variant Some protocols use tesamorelin every other day instead of daily, halving exposure. Outcomes are reduced but tolerability and cost improve. Not trial-validated; common in budget-constrained research.

The MOTS-C-omitted variant Reta + Tesa alone (the Metabolic Stack) is a common starting protocol. It captures the energy deficit and lean mass preservation pieces. MOTS-C is the optional layer that adds mitochondrial substrate partitioning on top.

The CJC + Ipa addition (the Shred & Bulk Stack) Adding CJC-1295 + Ipamorelin extends the GH amplification beyond what tesamorelin produces alone. This is the natural next step when a researcher wants to push lean-mass and recovery outcomes harder.

What the Stack Doesn't Do

Important caveats: - It does not replace exercise for cardiovascular adaptation, bone density, or skill-based performance - It does not address sleep, stress, or nutrient quality — confounds that dominate any real-world recomp signal - It does not eliminate dose-related side effects — reta GI symptoms still occur, tesamorelin's IGF-1 elevation still requires monitoring

The stack is a tool for studying body composition under controlled conditions, not a magic bullet.

Practical Sourcing

For a one-month block: - 1× Reta 20mg covers ~5 weeks at moderate titration (fewer at aggressive titration) - 3× Tesa 10mg covers ~30 days at 1 mg/night - 3× MOTS-C covers ~27 days at 8 mg/week

This is exactly what the Shredder Stack Complete bundle contains, which is why we built it: a full month of all three. The base Shredder Stack (1× of each) only carries ~10 days of Tesa and MOTS-C — a short pilot, or the opening of a longer study you re-supply monthly.

Closing

The Shredder Stack is mechanistically clean: three compounds, three different biological axes, complementary by design. The research case for combining them is stronger than for most stacks on the market because the overlap is genuinely minimal.

When you're ready to source a matched-batch protocol, code WELCOME gets you 35% off the Shredder Stack, Shredder Stack Complete, individual Reta / Tesa / MOTS-C vials, and bac water for reconstitution. Every vial ships with a COA and 99%+ HPLC purity verification.

Disclaimer: All information presented in this article is for educational and informational purposes only. Platinum Biolabs does not promote or endorse the use of peptides for human consumption. All products sold by Platinum Biolabs are intended strictly for laboratory and research use only. Consult a qualified healthcare professional before making any health-related decisions.